National Institute of Mental Health; Notice of Closed Meetings, 4155-4156 [06-690]

Download as PDF Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices Virology 2005, volume 29, pp 12394– 12400. In addition to licensing, the technology is available for further studies in application to vaccine development in animal models through collaborative research opportunities with the inventors. Please contact Dr. Yossef Raviv at yraviv@ncifcrf.gov. Dated: January 18, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6–909 Filed 1–24–06; 8:45 am] Dated: January 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–691 Filed 1–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council for Human Genome Research. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Initial Review Group; Genome Research Review Committee. Date: March 8–10, 2006. Time: March 8, 2006, 7 p.m to 8:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5635 Fishers Lane, Bethesda, MD 20892. Time: March 9, 2006, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5635 Fishers Lane, Bethesda, MD 20892. Time: March 10, 2006, 8:30 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5635 Fishers Lane, Bethesda, MD 20892. Contact Person: Rudy O. Pozzatti, PhD, Scientific Review Administrator, Office of Scientific Review, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892. 301–402–0838. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Name of Committee: National Advisory Council for Human Genome Research. Date: February 13–14, 2006. Open: February 13, 2006, 8:30 a.m. to 2 p.m. Agenda: To discuss matters of program relevance. Place: National Institutes of Health, 5635 Fisher Lane, Terrace Level Conference Room, Rockville, MD 20892. Closed: February 13, 2006, 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fisher Lane, Terrace Level Conference Room, Rockville, MD 20892. Closed: February 14, 2006, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fisher Lane, Terrace Level Conference Room, Rockville, MD 20892. Contact Person: Mark S. Guyer, PhD, Director for Extramural Research, National Human Genome Research Institute, 5635 Fisher Lane, Suite 4076, MSC 9305, BILLING CODE 4167–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health wwhite on PROD1PC61 with NOTICES National Human Genome Research Institute; Notice of Closed Meeting VerDate Aug<31>2005 18:26 Jan 24, 2006 Jkt 208001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 4155 Bethesda, MD 20892, 301–496–7531, guyerm@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.genome.gov/11509849, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: January 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–692 Filed 1–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITV Related Child Disorders. Date: February 8–9, 2006. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Crystal City Hotel, 1800 Jefferson Davis Highway, Arlington, VA 22202. 703–386–1111. Contact Person: Christopher S. Sarampote, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6148, MSC 9608, Bethesda, MD 20892– 9608. 301–443–1959. csarampo@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. E:\FR\FM\25JAN1.SGM 25JAN1 4156 Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITV—Schizophrenia and Aging. Date:≤ February 15, 2006. Time: 8:30 to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Tracy Waldeck, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6132, MSC 9608, Bethesda, MD 20852–9609. 301/435–0322. waldeckt@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: January 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–690 Filed 1–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings wwhite on PROD1PC61 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commerical property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Integrated Preclinical/ Clinical AIDS Vaccine Development (IPCAVD). Date: February 15, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, 6700B Rockledge Drive, Room 3129, Bethesda, MD 20892, (Telephone Conference Call). VerDate Aug<31>2005 18:26 Jan 24, 2006 Jkt 208001 Contact Person: Eleazar Cohen, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3129, 6700 B Rockledge Drive, Bethesda, MD 20892, (301) 435–3564, ec17w@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials Network (2). Date: February 15, 2006. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 1202, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Kenneth E. Santora, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2550, ks216i@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials Network (8). Date: February 16, 2006. Time: 9 a.m. to 4 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review Administrator, NIAID, DEA, Scientific Review Program, Room 2217, 6700–B Rockledge Drive, MSC– 7616, Bethesda, MD 20892–7616, (301) 496– 2550, bgustafson@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Unit for HIV/AIDS Clinical Trials Network (14)–ZAL1–TP–A–M3. Date: February 17, 2006. Time: 10 a.m. to 4 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, 6700 B, Rockledge Drive, 3143, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Thames E. Pickett, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–496–2550, pickettte@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials Network (Sep 10). Date: February 21, 2006. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Darren D Sledjeski, PhD, Scientific Review Administrator, NIAID, PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 DEA, Scientific Review Program, Room 3253, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, 301–451–2638. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 18, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–693 Filed 1–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Units for HIV/AIDS Clinical Trials Network (3)—ZAI1–SR–A–M2. Date: February 13, 2006. Time: 11 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call). Contact Person: Stefani T. Rudnick, Ph.D., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616. 301–496–2500. srudnick@niaid/nih/gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel. Partnerships to Develop Tools to Evaluate Women’s Health. Date: February 17, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814. E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 71, Number 16 (Wednesday, January 25, 2006)]
[Notices]
[Pages 4155-4156]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-690]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; ITV Related Child Disorders.
    Date: February 8-9, 2006.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton Crystal City Hotel, 1800 Jefferson Davis 
Highway, Arlington, VA 22202. 703-386-1111.
    Contact Person: Christopher S. Sarampote, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6148, MSC 9608, Bethesda, MD 20892-9608. 301-443-1959. 
csarampo@mail.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.


[[Page 4156]]


    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; ITV--Schizophrenia and Aging.
    Date: February 15, 2006.
    Time: 8:30 to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Tracy Waldeck, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Institute 
of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., 
Room 6132, MSC 9608, Bethesda, MD 20852-9609. 301/435-0322. 
waldeckt@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)

    Dated: January 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-690 Filed 1-24-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.